As of Mar 27
| +0.13 / +1.79%|
The 3 analysts offering 12-month price forecasts for STAAR Surgical Company have a median target of 12.00, with a high estimate of 13.00 and a low estimate of 6.00. The median estimate represents a +62.60% increase from the last price of 7.38.
The current consensus among 4 polled investment analysts is to Hold stock in STAAR Surgical Company. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.